Molecular Imaging: Page 165

New budget revives pass-through status of radiotracers

By AuntMinnie.com staff writers

New budget legislation signed last week by President Donald Trump will reverse the decision made by the U.S. Centers for Medicare and Medicaid Services to remove the pass-through status of several radiopharmaceuticals on January 1.

March 25, 2018

SNMMI urges CMS to classify radiotracers as drugs

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has joined other advocacy groups and vendors in Washington, DC, last week to campaign for a bill that would require the U.S. Centers for Medicare and Medicaid Services (CMS) to reclassify diagnostic radiopharmaceuticals as drugs.

March 19, 2018

FDA report tackles Philips complaint handling

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has released a report on its inspection of the Cleveland-area manufacturing facility operated by Philips Healthcare.

March 19, 2018

CereHealth gets FDA nod for image viewer

By AuntMinnie.com staff writers

CereHealth, a subsidiary of neurodiagnostic firm CereScan, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CereMetrix Silver image viewer.

March 12, 2018

Lantheus touts cardiac PET tracer study at ACC

By AuntMinnie.com staff writers

Lantheus Medical Imaging reported encouraging results from a phase II study of LMI 1195, an F-18 tracer for use in cardiac PET to evaluate myocardial presynaptic sympathetic nerve function. The findings were presented on Monday at the American College of Cardiology (ACC) annual meeting in Orlando, FL.

March 12, 2018

ACC: PET/CT calcium scans could foretell cardiac events

By Wayne Forrest

By using PET/CT to measure the level of calcium in the coronary arteries during stress tests, clinicians can better predict which patients are at high risk of heart disease, according to a study presented on Monday at the American College of Cardiology (ACC) annual conference in Orlando, FL.

March 12, 2018

ACC: PET tops SPECT for severe coronary artery disease

By Wayne Forrest

PET is significantly more proficient than SPECT in detecting severe obstructive coronary artery disease, enabling more appropriate use of revascularization treatment, according to a study presented on Saturday at the American College of Cardiology (ACC) meeting in Orlando, FL.

March 11, 2018

Novel PET tracer may improve NSCLC patient management

By AuntMinnie.com staff writers

Chinese and U.S. researchers have developed a novel PET tracer that may enhance the management of patients with non-small cell lung cancer (NSCLC), according to a study published online in the March 7 issue of Science Translational Medicine.

March 8, 2018

Foundation awards grants for NET research

By AuntMinnie.com staff writers

The Neuroendocrine Tumor Research Foundation (NETRF) has awarded six new research grants totaling $1.85 million, approximately $1.5 million of which relates to nuclear medicine/radiology research.

March 8, 2018

PET/MRI falls short in lymph node metastases analysis

By Wayne Forrest

While the combination of PET and MRI has shown promise for detecting and characterizing some forms of cancer, the hybrid modality does not match the accuracy of invasive sentinel lymph node biopsy in melanoma patients, according to a study presented at ECR 2018 in Vienna.

March 8, 2018

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

March 6, 2018

Novel PET agent targets copper in prostate tumors

By AuntMinnie.com staff writers

Italian researchers are reporting progress with a novel PET imaging agent that targets copper accumulation in tumors to detect prostate cancer recurrence. Their results were published in the March issue of the Journal of Nuclear Medicine.

March 5, 2018

Previous Page

Page 165 of 612

Next Page